FDA approvals on par with last year; regulatory news slower in August Sep. 18, 2020 By Karen Carey No Comments While COVID-19 is responsible for about 14% of the regulatory data collected by BioWorld in 2020 and even though numerous clinical trials have suffered delays, the pandemic does not appear to have slowed the pace of the FDA’s approval process.Read More